More than 1,000 women a year with advanced cancer could benefit from capivasertib which can slow the disease.
About BBC News
This author has not written his bio yet.
But we are proud to say that BBC News contributed 3230 entries already.
This author has not written his bio yet.
But we are proud to say that BBC News contributed 3230 entries already.
